Daily primaquine is effective for prophylaxis against falciparum malaria in kenya: Comparison with mefloquine, doxycycline, and chloroquine plus proguanil

Journal of Infectious Diseases

Volumn 171, Issue 6, 1995, Pages 1569-1575

  Weiss, Walter R ^a,b,c   Oloo, Aggrey J ^a,b,c   Johnson, Anthony ^a,b,c   Koech, Davy ^a,b,c   Hoffman, Stephen L ^a,b,c  

^a Naval Medical Research Institute Detachment Kenya ^*  (Kenya)

^b US Army Medical Research Unit Kenya   (Kenya)

^c NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DOXYCYCLINE; MEFLOQUINE; MULTIVITAMIN; PRIMAQUINE; PROGUANIL;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; INFECTION PREVENTION; KENYA; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; CHILD; CHLOROGUANIDE; CHLOROQUINE; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; HUMANS; KENYA; MALARIA, FALCIPARUM; MEFLOQUINE; PRIMAQUINE;

EID: 0029062360     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/171.6.1569     Document Type: Article

References (23)

1. Hoffman SL. Prevention of malaria [editorial]. JAMA 1991;265:398-9.
2. White NJ. Drug treatment and prevention of malaria. Eur J Clin Pharmacol 1988;34:1-14.
3. Wyler DJ. Malaria chemoprophylaxis for the traveler. N Engl J Med 1993;329:31-7.
4. Lobel HO, Bernard KW, Williams SL, Hightower AW, Patchen LC, Campbell CC. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. JAMA 1991;265:361-4.
5. Bourdreau E, Schuster B, Sanchez J, et al. Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993;44:257-65.
6. James SP. Some general results of a study of induced malaria in England. Trans R Soc Trop Med Hyg 1931;25:477-525.
7. Arnold J, Alving AS, Hockwald RS, et al. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama P-F-6 strain). J Lab Clin Med 1955;46:391-7.
8. Hollingdale MR. In vitro testing of antimalarial tissue schizonticides. In: Wernsdorfer WH, Trigg PI, eds. Primaquine. New York: John Wiley & Sons. 1984:129-38.
9. Puri SK, Dutta GP. Differential sensitivity of the pre-erythrocytic stages of Plasmodium c ynomolgi B to the prophylactic action of primaquine. Trop Med Parasitol 1992;43:70-1.
10. Shoa B, Ye X. Tissue schizonticidal effect of trifluoroacetyl primaquine in Plasmodium yoelli infected mice and Plasmodium cvnomolgi infected monkeys. SE Asian J Trop Med Public Health 1991;22:81-3.
11. Powell RD, Brewer GJ. Effects of pyrimethamine, chlorguanide, and primaquine against exoerythrocytic forms of a strain of chloroquine- resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg 1967; 16:693-8.
12. Hoffman SL, Oster CN, Wollett GR, et al. Naturally acquired antibodyies to sporozoites do not prevent malaria: vaccine development implications. J Immunol 1989; 142:1299-303.
13. Beier JC, Perkins PV, Onyango FK. et al. Characterization of malaria transmission by Anopheles (diptera: Culicidae) in western Kenya in preparation for malaria vaccine trials. J Med Entomol 1990;27: 570-7.
14. De Leenheer AP, Nelis HJ. Doxycycline determination in human serum and urine by high-performance liquid chromatography. J Pharm Sci 1979;68:999-1002.
15. Baker JK, McChesney JD, Hu fiord CD, Clark AM. High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. J Chroma- togr B Biomed Appl 1992;230:69-77.
16. Bergquist Y, Hellgren U, Churchill F. High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr 1985;432:253-68.
17. Ward SA, Watkins WM, Mberu E, et al. Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br J Clin Pharmacol 1989;27:781-7.
18. Shmulklarsky MJ, Boudreau EF, Pang LW, et al. Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers. Ann Intern Med 1994; 120:294-9.
19. Ward SA, Mihaly GW, Edwards G, et al. Pharmacokinetics of prima quine in man. II. Comparison of acute vs. chronic dosage in Thai subjects. Br J Clin Pharmacol 1985; 19:751-5.
20. Clyde DF. Clinical problems associated with the use of primaquine as a tissue schizonticidal and gametocidal drug. Bull World Health Organ 1981;59:391-5.
21. Snow RW, Lindsay SW, Hayes RJ, Greenwood BM. Permethrin treated bed nets (mosquito nests) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg 1988;82:838-42.
22. Lines J, Armstrong JRM. For a few parasites more: inoculum size, vector control, and strain-specific immunity to malaria. Parasitol Today 1992;8:381-3.
23. Rieckmann KH, Yeo AET, Davis DR, Hutton DC, Wheatley PF, Simpson R. Recent military experience with malaria chemoprophylaxis. Med J Aust 1993; 158:446-9.